Allakos Inc
Biotechnology ResearchCalifornia, United States51-200 Employees
Allakos Inc. is a publicly traded clinical-stage biopharmaceutical company developing first-in-class antibody-based therapeutics to treat allergic and inflammatory diseases.
Cutting-Edge Therapeutics Allakos Inc. is a biopharmaceutical company developing innovative antibody-based therapeutics for allergic and inflammatory diseases, showcasing potential sales opportunities for pharmaceutical partnerships and collaborations.
Expanding Scientific Reach With recent launches in scientific journals and development of novel compounds such as AK006 and Siglec-6, Allakos Inc. is expanding its scientific footprint, creating opportunities for engagement with research institutions and healthcare providers.
Established Board Additions Additions to Allakos Inc.'s board, such as Neil Graham and Amy L. Ladd, signify a strategic focus on leadership. Leveraging these key personnel can open avenues for strategic alliances or business development opportunities.
Strategic Financial Position Having recently gone public and raised $150 million, Allakos Inc. demonstrates financial stability and growth potential. This financial strength positions them well for sales discussions, investments, and partnerships.
Industry Partnerships Allakos Inc.'s partnerships with industry players like Lonza highlight collaboration potential for production and distribution. Leveraging these partnerships can lead to expanded market presence and sales growth.
Allakos Inc uses 8 technology products and services including SiteCatalyst, Oracle, Oracle ERP, and more. Explore Allakos Inc's tech stack below.
Allakos Inc Email Formats | Percentage |
FLast@allakos.com | 84% |
First.Last@allakos.com | 14% |
FirstLast@allakos.com | 1% |
LastFirst@allakos.com | 1% |
Biotechnology ResearchCalifornia, United States51-200 Employees
Allakos Inc. is a publicly traded clinical-stage biopharmaceutical company developing first-in-class antibody-based therapeutics to treat allergic and inflammatory diseases.
Allakos Inc has raised a total of $150M of funding over 5 rounds. Their latest funding round was raised on Sep 19, 2022 in the amount of $150M.
Allakos Inc's revenue is in the range of $10M$50M
Allakos Inc has raised a total of $150M of funding over 5 rounds. Their latest funding round was raised on Sep 19, 2022 in the amount of $150M.
Allakos Inc's revenue is in the range of $10M$50M